NLC and MedTech Europe publish reflection paper on how to improve the innovative landscape of Europe in health tech
MedTech Europe in collaboration with NLC published a reflection paper outlining how Europe can provide a more attractive landscape for Innovation in health tech….
Unleash the potential of healthtech innovation. Together.
Ever since the Covid-19 crisis started, NLC has adopted the strategy “prepare for the worst, prepare for the best”. Now, six months later, we…
FlowView Diagnostics
Multi-parameter flow cytometry is a powerful analytical tool, enabling rapid measurement of multiple, physical and chemical characteristics of individual cells. Examples of clinical applications…
Lamina
Cartilage damage in the knee affects millions of people worldwide with a continued rise in incidence. Currently, the only conventional solutions are symptoms (pain,…
How healthtech innovations arise during the COVID-19 crisis
At the start of the COVID-19 outbreak in Europe, NLC developed a website for people to share COVID-19 related ideas and innovations. With over…
NLC and MD squared conclude Framework Agreement for Venture Support
Amsterdam/Eindhoven NLC – the European HealthTech Venture Builder, has concluded a Framework Agreement with the Eindhoven based MD squared, a Medical Consultancy for Medical…